articles
MD Becker Partners publishes the Life Science Digest newsletter, which contains original articles on medical, financial, communications, marketing, and regulatory topics relevant to the biotechnology, pharmaceutical, and medical device industries. To view these articles, please visit the Life Science Digest newsletter site (www.lifesciencedigest.com).
MD Becker Partners also publishes original industry research, such as the firm's 150-page report on the cancer immunotherapy market that profiled nearly 40 companies and reviewed some of the scientific, medical, clinical, and financial aspects of the sector.
We have also authored or contributed to other articles, journal publications, and abstracts. Note: access to full text versions may be available by clicking on the story dates below.
Newsletter articles
8/23/2010 - "Stem Cell Competition Heating Up"
7/11/2010 - "Monoclonal Antibody Companies Command Premiums"
7/1/2010 - "Five Key Factors Weighing on Dendreon"
6/3/2010 - "Cancer Immunotherapy to Take Center Stage at ASCO"
4/16/2010 - "Cyclin-dependent Cancer Confab Preview"
4/7/2010 - "Cancer Vaccine Therapies: Failures and Future Opportunities"
3/7/2010 - "For Biotechnology in 2010, it’s Déjà vu All over Again"
2/28/2010 - "Gut Check Time for GVHD Companies: BMT Tandem Meetings Review"
Scientific publications
12/8/2008 - "Phase I Study of the Akt-Inhibitor Triciribine Phosphate Monohydrate in Patients with Advanced Hematologic Malignancy" in Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 2987
7/1/2008 - "The use of chelated radionuclide (samarium-153-ethylene-diamine-tetra-methylene-phosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing" in Clin Cancer Res 2008 Jul 1;14(13):4241-9
9/12/2006 - "Development of optimal Lu-177 labeled monoclonal antibody (7E11) constructs (CYT-500) for radioimmunotherapy of hormone refractory prostate cancer" Abstract #B45 from the 2006 American Association for Cancer Research (AACR) annual meeting
Additional articles
9/18/2008 - "The Treatment of Palmar-plantar Erythrodysesthesia" By Michael D. Becker for MDNG
6/1/2008 - "Honing In on Chemoresistance Pathways" By Michael D. Becker for GEN (Genetic Engineering & Biotechnology News)
9/1/2007 - "Radiopharmaceuticals Need a Jump-STaRT" By Michael D. Becker for Oncology Business Review
11/6/2000 - "More Akin to Skin - Comparing and contrasting the independent efforts of Advanced Tissue Sciences and Organogenesis in the emerging field of tissue engineering" By Michael D. Becker for the Beck On Biotech newsletter